The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial

A. Rody*, T. Karn, C. Solbach, R. Gaetje, M. Munnes, S. Kissler, E. Ruckhäberle, G. v. Minckwitz, S. Loibl, U. Holtrich, M. Kaufmann

*Corresponding author for this work
55   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'The erbB2+ cluster of the intrinsic gene set predicts tumor response of breast cancer patients receiving neoadjuvant chemotherapy with docetaxel, doxorubicin and cyclophosphamide within the GEPARTRIO trial'. Together they form a unique fingerprint.
Sort by

Immunology and Microbiology